[HTML][HTML] Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy

J Mensa, J Barberán, A Soriano, P Llinares… - Revista Española de …, 2018 - ncbi.nlm.nih.gov
Pseudomonas aeruginosa is characterized by a notable intrinsic resistance to antibiotics,
mainly mediated by the expression of inducible chromosomic β-lactamases and the …

Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa

GM Rossolini, E Mantengoli - Clinical Microbiology and …, 2005 - Wiley Online Library
Pseudomonas aeruginosa is one of the leading causes of nosocomial infections. Severe
infections, such as pneumonia or bacteraemia, are associated with high mortality rates and …

Current choices of antibiotic treatment for Pseudomonas aeruginosa infections

D Ibrahim, JF Jabbour, SS Kanj - Current Opinion in Infectious …, 2020 - journals.lww.com
Factors that guide clinical decisions for empiric and directed P. aeruginosa therapy include
the epidemiology, the patient's risk factors, the site of infection, and the available treatment …

Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections

ED Santos, CM Jiménez, L del Río-Carbajo… - Medicina Intensiva …, 2022 - Elsevier
Pseudomonas aeruginosa is the microorganism most frequently involved in the main ICU-
acquired infections, with special importance in ventilator associated pneumonia. Its …

Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy.

P Ruiz-Garbajosa, R Cantón - Revista Espanola de …, 2017 - search.ebscohost.com
Pseudomonas aeruginosa is one of the major pathogens causing hospital-acquired
infections. It can easily develop antibiotic resistance through chromosomal mutations or by …

[HTML][HTML] Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium

N Mesaros, P Nordmann, P Plésiat… - Clinical microbiology …, 2007 - Elsevier
Pseudomonas aeruginosa is a major cause of nosocomial infections. This organism shows
a remarkable capacity to resist antibiotics, either intrinsically (because of constitutive …

Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options

M Chatterjee, CP Anju, L Biswas, VA Kumar… - International Journal of …, 2016 - Elsevier
Pseudomonas aeruginosa is a leading cause of nosocomial infections and is responsible
for∼ 10% of all hospital-acquired infections worldwide. It continues to pose a therapeutic …

[PDF][PDF] Overview of multidrug-resistant Pseudomonas aeruginosa and novel therapeutic approaches

M Porras Gómez, J Vega Baudrit, S Núñez Corrales - 2012 - repositorio.conare.ac.cr
Gram-negative bacilli Pseudomonas aeruginosa is an important pathogen in hospitalized
patients, contributing to their morbidity and mortality due to its multiple resistance …

[HTML][HTML] How to manage Pseudomonas aeruginosa infections

M Bassetti, A Vena, A Croxatto, E Righi, B Guery - Drugs in context, 2018 - ncbi.nlm.nih.gov
Infections with Pseudomonas aeruginosa have become a real concern in hospital-acquired
infections, especially in critically ill and immunocompromised patients. The major problem …

Therapeutic guidelines for Pseudomonas aeruginosa infections

H Giamarellou - International journal of antimicrobial agents, 2000 - Elsevier
Pseudomonas aeruginosa nowadays is encountered among the leading pathogen in (i) ICU
pneumonia;(ii) nosocomial bacteremia and AIDS primary bacteremia;(iii) iv drug users …